References
- Neyzi O, Bustos J, Dale JH, Jr, Rawson R W. Gynecomastia in adolescent boys. JAMA 1961; 178: 449–54
- Gleam D. Braunstein. Gynecomastia. NEJM Feb 18, 1993; 328(7)490–95
- Bruce D C, Mel Sorensen J, Vena DA, et al. Treatment of hairy cell leukaemia with 2-chlorodwxyadenosine via the group C protocol mechanism of the National Cancer Institute: A report of 979 patients. JCO 1998; 16(9)3007–15
- Edmondson H A, Glass S J, Soll S N. Gynecomastia associated with cirrhosis of liver. Roc Soc Exp Biol Med 1939; 42: 97–99
- Ernest Beutler. Cladribine (2-chlorodeoxyadenosine). Lancet 1992; 340: 952–56
- Camera C J, Terai C, Lotz M, et al. Potency toxicity of 2-chlorodeoxyadenoside towards human monocytes in vitro and in vivo: a novel approach to immunosuppressive therapy. J Clin Invest 1990; 86: 1480–88
- Turner AR, Morrish DW, Berry J, MacDonald N. Gynecomastia after cytotoxic therapy for metastatic testicular cancer. Arch Intern Med 1982; 142: 896–97
- Sherins RJ, Charles L MO, John L Z. Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease. NEJM 1978; 299: 12–16